Development of arrestin-biased dopamine D1 receptor (D1R) ligand for the treatment of Parkinson's disease with minimal L-DOPA induced dyskinesia

Administered By

Awarded By

Contributors

Start/End

  • February 1, 2023 - July 31, 2024